Sec Form 4 Filing - Hippel James @ BIO-TECHNE Corp - 2020-08-05

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Hippel James 2. Issuer Name and Ticker or Trading Symbol BIO-TECHNE Corp [ TECH] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) 614 MCKINLEY PLACE N.E. 3. Date of Earliest Transaction (MM/DD/YY) 08/05/2020 (Street) MINNEAPOLIS, MN55413 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 6,883 ( 1 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Options (Right to Buy) $ 108.49 ( 3 ) 08/07/2022 Common Stock 15,909 15,909 D Stock Options (Right to Buy) $ 106.59 ( 3 ) 08/18/2023 Common Stock 30,400 30,400 D Stock Options (Right to Buy) $ 106.59 ( 4 ) 08/18/2023 Common Stock 40,533 40,533 D Restricted Stock Units ( 2 ) ( 5 ) ( 5 ) Common Stock 4,438 4,438 D Stock Options (Right to Buy) $ 125.05 ( 5 ) 08/09/2024 Common Stock 24,460 24,460 D Stock Options (Right to Buy) $ 125.05 ( 6 ) 08/09/2024 Common Stock 32,613 32,613 D Restricted Stock Units ( 2 ) ( 7 ) ( 7 ) Common Stock 3,383 3,383 D Stock Options (Right to Buy) $ 177.32 ( 7 ) 08/08/2025 Common Stock 18,066 18,066 D Stock Options (Right to Buy) $ 177.32 ( 8 ) 08/08/2025 Common Stock 24,089 24,089 D Restricted Stock Units ( 2 ) ( 9 ) ( 9 ) Common Stock 3,938 3,938 D Stock Options (Right to Buy) $ 190.41 ( 9 ) 08/07/2026 Common Stock 19,936 19,936 D Stock Options (Right to Buy) $ 190.41 ( 10 ) 08/07/2026 Common Stock 26,581 26,581 D Restricted Stock Units ( 2 ) 08/05/2020 A 3,219 ( 11 ) ( 11 ) Common Stock 3,219 $ 0 3,219 D Stock Options (Right to Buy) $ 267.87 08/05/2020 A 14,360 ( 11 ) 08/05/2027 Common Stock 14,360 $ 0 14,360 D Stock Options (Right to Buy) $ 267.87 08/05/2020 A 19,147 ( 12 ) 08/05/2027 Common Stock 19,147 $ 0 19,147 D Stock Options (Right to Buy) $ 267.87 08/05/2020 A 8,325 ( 13 ) 08/05/2027 Common Stock 8,325 $ 0 8,325 D Stock Options (Right to Buy) $ 267.87 08/05/2020 A 8,325 ( 14 ) 08/05/2027 Common Stock 8,325 $ 0 8,325 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Hippel James 614 MCKINLEY PLACE N.E. MINNEAPOLIS, MN55413 Chief Financial Officer Signatures /s/ Brenda S. Furlow, Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed. 08/07/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Reflects a correction to the previously-reported number. ( 2 )Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. ( 3 )Fully exercisable. ( 4 )Options to purchase 10,134 shares vest on 8/18/2017 and options to purchase 10,133 shares vest on each of 8/18/2018, 8/18/2019 and 8/18/2020. ( 5 )Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). ( 6 )Options to purchase 8,153 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and options to purchase 8,154 shares vest on 8/9/2021. ( 7 )Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). ( 8 )Options to purchase 6,023 shares vest on 8/8/2019 and options to purchase 6,022 shares vest on each of 8/8/2020, 8/8/2021 and 8/8/2022. ( 9 )Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). ( 10 )Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023. ( 11 )Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). ( 12 )Options to purchase 4,787 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023 and options to purchase 4,786 shares vest on 8/5/2024. ( 13 )Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023. ( 14 )Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.